Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children

dc.contributor.authorNg Kenney
dc.contributor.authorAnand Vibha
dc.contributor.authorStavropoulos Harry
dc.contributor.authorVeijola Riitta
dc.contributor.authorToppari Jorma
dc.contributor.authorMaziarz Marlena
dc.contributor.authorLundgren Markus
dc.contributor.authorWaugh Kathy
dc.contributor.authorFrohnert Brigitte I
dc.contributor.authorMartin Frank
dc.contributor.authorLou Olivia
dc.contributor.authorHagopian William
dc.contributor.authorAchenbach Peter
dc.contributor.authorT1DI Study Group
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=lastentautioppi|en=Paediatrics and Adolescent Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)|
dc.contributor.organization-code1.2.246.10.2458963.20.42471027641
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id176875368
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/176875368
dc.date.accessioned2022-11-29T15:52:26Z
dc.date.available2022-11-29T15:52:26Z
dc.description.abstract<p><strong>Aims/hypothesis: </strong>The aim of this study was to explore the utility of islet autoantibody (IAb) levels for the prediction of type 1 diabetes in autoantibody-positive children.</p><p><strong>Methods: </strong>Prospective cohort studies in Finland, Germany, Sweden and the USA followed 24,662 children at increased genetic or familial risk of developing islet autoimmunity and diabetes. For the 1403 who developed IAbs (523 of whom developed diabetes), levels of autoantibodies against insulin (IAA), glutamic acid decarboxylase (GADA) and insulinoma-associated antigen-2 (IA-2A) were harmonised for analysis. Diabetes prediction models using multivariate logistic regression with inverse probability censored weighting (IPCW) were trained using 10-fold cross-validation. Discriminative power for disease was estimated using the IPCW concordance index (C index) with 95% CI estimated via bootstrap.</p><p><strong>Results: </strong>A baseline model with covariates for data source, sex, diabetes family history, HLA risk group and age at seroconversion with a 10-year follow-up period yielded a C index of 0.61 (95% CI 0.58, 0.63). The performance improved after adding the IAb positivity status for IAA, GADA and IA-2A at seroconversion: C index 0.72 (95% CI 0.71, 0.74). Using the IAb levels instead of positivity indicators resulted in even better performance: C index 0.76 (95% CI 0.74, 0.77). The predictive power was maintained when using the IAb levels alone: C index 0.76 (95% CI 0.75, 0.76). The prediction was better for shorter follow-up periods, with a C index of 0.82 (95% CI 0.81, 0.83) at 2 years, and remained reasonable for longer follow-up periods, with a C index of 0.76 (95% CI 0.75, 0.76) at 11 years. Inclusion of the results of a third IAb test added to the predictive power, and a suitable interval between seroconversion and the third test was approximately 1.5 years, with a C index of 0.78 (95% CI 0.77, 0.78) at 10 years follow-up.</p><p><strong>Conclusions/interpretation: </strong>Consideration of quantitative patterns of IAb levels improved the predictive power for type 1 diabetes in IAb-positive children beyond qualitative IAb positivity status.</p>
dc.format.pagerange104
dc.format.pagerange93
dc.identifier.eissn1432-0428
dc.identifier.jour-issn0012-186X
dc.identifier.olddbid190283
dc.identifier.oldhandle10024/173374
dc.identifier.urihttps://www.utupub.fi/handle/11111/34679
dc.identifier.urlhttps://doi.org/10.1007/s00125-022-05799-y
dc.identifier.urnURN:NBN:fi-fe2022112968044
dc.language.isoen
dc.okm.affiliatedauthorToppari, Jorma
dc.okm.affiliatedauthorDataimport, Lastentautioppi
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSpringer
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1007/s00125-022-05799-y
dc.relation.ispartofjournalDiabetologia
dc.relation.volume66
dc.source.identifierhttps://www.utupub.fi/handle/10024/173374
dc.titleQuantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s00125-022-05799-y.pdf
Size:
965.35 KB
Format:
Adobe Portable Document Format